Perronne in the NEJM: ‘Recovery’ trial contested – is this finally a breach in the denial around hydroxychloroquine?
The British Recovery study testing HCQ in patients with COVID-19 used very high doses of hydroxychloroquine, doses that we can qualify as dangerously toxic.